Insiders Abliva AB Deutsche Boerse AG

Equities

NTP

SE0002575340

Delayed Deutsche Boerse AG Other stock markets 03:46:25 2024-07-17 EDT			5-day change	1st Jan Change
0.0128 ^EUR	+0.79%		+70.67%	+4.07%

05-30	Abliva Concludes Dosing in Mid-stage Study of Mitochondrial Disease Drug	MT
05-30	Abliva AB Announces Completion of 24 Weeks of Dosing in Wave 1 of the Falcon Study of KL1333 in Primary Mitochondrial Disease	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Abliva AB Announces Resignation of Edwin Moses as Director	23-05-04	CI
Abliva AB Elects Edwin Moses as New Board Member	23-03-08	CI
Abliva Announces CEO Changes, with Effect from February 3rd	21-01-20	CI
Abliva AB Announces Resignation of Magnus Persson From Board of Directors	20-10-08	CI
NeuroVive Pharmaceutical AB Elects Roger Franklin as New Board Member; Approves Amendment to the Articles of Association	20-05-20	CI
NeuroVive Pharmaceutical AB Elects Magnus Persson as New Board Member	19-04-25	CI
NeuroVive Pharmaceutical AB Appoints Denise Goode as New Board Member	18-04-27	CI
NeuroVive Pharmaceutical AB Announces Board Changes	17-11-07	CI
NeuroVive Pharmaceutical AB Appoints Daniel Schale as Director of Communications	17-10-04	CI
NeuroVive Pharmaceutical AB Appoints Mark Farmery as Vice President Business Development	17-09-01	CI
Neurovive Pharmaceutical AB Appoints Philippe Gallay and Massimo Pinzani as Scientific Advisors	17-02-22	CI
NeuroVive Pharmaceutical AB: Annual General Meeting 2017 and Nomination Committee	16-10-26	PU
NeuroVive Pharmaceutical AB: Annual General Meeting 2017 and Nomination Committee	16-10-26	BU
NeuroVive Pharmaceutical AB's Chief Operating Officer Jan Nilsson Leaves the Company	16-08-24	CI
NeuroVive Pharmaceutical AB Appoints Cecilia Hofvander as Investor Relations and Communications Director, Effective June 1, 2016	16-04-11	CI
NeuroVive Pharmaceutical AB Announces Executive Changes	16-02-23	CI
NeuroVive Pharmaceutical AB to Appoint Dr. Magnus Hansson as Chief Medical Officer, Effective as of January 1, 2016	15-10-23	CI
NeuroVive Pharmaceutical AB Announces Executive Changes	15-09-01	CI
NeuroVive Pharmaceutical AB Elects Fredrik Olsson as Board Member	15-03-30	CI
NeuroVive Establishes Subsidiary in Taiwan, NeuroVive Pharmaceutical Asia, Inc; Appoints Michael L. Huang as CEO of NeuroVive's Asian Group	15-02-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Abliva AB Deutsche Boerse AG

Equities

NTP

SE0002575340

Insiders

Filters